Behind The Blockbuster: Investors Sound Off On Biogen's Future With Spinraza
Executive Summary
Entering 2017 with freshly approved Spinraza and new CEO Michel Vounatsos, Biogen still faces challenges and uncertainty. A poll of investors highlights expectations for the company.